<DOC>
	<DOCNO>NCT00244400</DOCNO>
	<brief_summary>The purpose present study examine possible association hepatic CYP3A activity susceptibility femur head necrosis patient treat corticosteroid .</brief_summary>
	<brief_title>Examine Possible Association Hepatic CYP3A Activity Susceptibility Femur Head Necrosis</brief_title>
	<detailed_description>Femur head necrosis one major side effect corticosteroid therapy . Since corticosteroid metabolize hepatic cytochrome P-450 ( CYP ) 3A , low endogenous activity enzyme may contribute pathogenesis ONFH . The purpose present study examine possible association hepatic CYP3A activity susceptibility femur head necrosis patient treat corticosteroid .</detailed_description>
	<mesh_term>Necrosis</mesh_term>
	<mesh_term>Femur Head Necrosis</mesh_term>
	<criteria>Clinical diagnosis avascular necrosis femur Old age ( &gt; 70 year ) Severe hepatic renal dysfunction Heart disease Current use know CYP3Ainducing inhibit drug Morbid obesity</criteria>
	<gender>All</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2006</verification_date>
	<keyword>Femur Head Necrosis</keyword>
	<keyword>CYP3A</keyword>
</DOC>